Catalent Competitors

CTLT Stock  USD 57.98  0.16  0.28%   
Catalent competes with MiMedx, Moleculin Biotech, Madrigal Pharmaceuticals, Agilent Technologies, and Equillium; as well as few others. The company conducts business under Pharmaceuticals sector and is part of Health Care industry. Analyzing Catalent competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Catalent to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Catalent Correlation with its peers.
For more information on how to buy Catalent Stock please use our How to Invest in Catalent guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Catalent competition on your existing holdings.
  
Return on Investment is likely to drop to -2.08 in 2024. Return on Average Assets is likely to drop to -0.03 in 2024. At this time, Catalent's Revenue to Assets are comparatively stable as compared to the past year. Net Current Assets as percentage of Total Assets is likely to gain to 10.62 in 2024, whereas Assets Non Current are likely to drop slightly above 7.4 B in 2024.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Catalent's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Catalent in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
54.4157.1059.79
Details
Intrinsic
Valuation
LowRealHigh
52.8955.5858.27
Details
13 Analysts
Consensus
LowTargetHigh
40.0048.6058.00
Details
Earnings
Estimates (7)
LowProjected EPSHigh
-0.1-0.06-0.03
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Catalent. Your research has to be compared to or analyzed against Catalent's peers to derive any actionable benefits. When done correctly, Catalent's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Catalent.

Catalent Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Catalent and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Catalent and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Catalent does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
AMDXG
MEKA
MDGLMDXG
AMDGL
MCRBMBRX
MEMBRX
  
High negative correlations   
MBIOA
MBIOMDXG
MBIOMDGL
KAEQ
MBIOEQ
MEEQ

Risk-Adjusted Indicators

There is a big difference between Catalent Stock performing well and Catalent Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Catalent's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Catalent and related stocks such as MiMedx Group, Moleculin Biotech, and Madrigal Pharmaceuticals Net Income Over Time
Select Fundamental
201020112012201320142015201620172018201920202021202220232024
MDXG(4.1 M)(4.1 M)(4.1 M)(4.1 M)6.2 M29.4 M12 M64.7 M(30 M)(25.6 M)(83.3 M)(16.4 M)(36.8 M)(33.1 M)(34 M)
MBRX(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(365.8 K)(3.9 M)(9.8 M)(11.9 M)(13.2 M)(17.4 M)(15.9 M)(29 M)(26.1 M)(26.8 M)
MDGL(90.2 M)(90.2 M)(90.2 M)(90.2 M)(86.2 M)(6.8 M)(26.4 M)(31.2 M)(32.8 M)(83.9 M)(202.2 M)(241.8 M)(295.4 M)(265.8 M)(272.8 M)
A734 M734 M734 M549 M401 M462 M684 M316 M1.1 B719 M1.2 B1.3 B1.2 B1.4 B1.2 B
EQ(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(13.2 M)(25.6 M)(29.8 M)(39.1 M)(62.4 M)(56.2 M)(57.7 M)
MBIO(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(31.3 M)(30.7 M)(46.4 M)(60 M)(66.4 M)(77.5 M)(69.8 M)(75.3 M)
MCRB(6.1 M)(6.1 M)(6.1 M)(6.1 M)(16.7 M)(54.8 M)(91.6 M)(89.4 M)(98.9 M)(70.3 M)(89.1 M)(65.6 M)(250.2 M)(225.1 M)(231.1 M)
KA(15.7 M)(15.7 M)(15.7 M)(15.7 M)(15.8 M)(25 M)(37.2 M)(59.4 M)(61.8 M)(31.2 M)(57.5 M)(11.8 M)(63.4 M)(57.1 M)(61.6 M)
ME(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(183.5 M)(250.9 M)(183.6 M)(217.5 M)(311.7 M)(280.5 M)(302.6 M)

Catalent and related stocks such as MiMedx Group, Moleculin Biotech, and Madrigal Pharmaceuticals Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Catalent financial statement analysis. It represents the amount of money remaining after all of Catalent operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Catalent Competitive Analysis

The better you understand Catalent competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Catalent's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Catalent's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CTLTMDXGMBRXMDGLAEQMBIOMCRBKAME
 0.28 
 57.98 
Catalent
 0.25 
 8.04 
MiMedx
 1.96 
 0.50 
Moleculin
 1.47 
 229.71 
Madrigal
 0.52 
 134.14 
Agilent
 8.70 
 3.00 
Equillium
 1.53 
 1.29 
Mustang
 0.95 
 1.04 
Seres
 8.13 
 2.60 
Kineta
 7.69 
 0.72 
23Andme
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Catalent Competition Performance Charts

Five steps to successful analysis of Catalent Competition

Catalent's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Catalent in relation to its competition. Catalent's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Catalent in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Catalent's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Catalent, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Catalent position

In addition to having Catalent in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Casinos Thematic Idea Now

Casinos
Casinos Theme
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Catalent is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catalent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catalent Stock. Highlighted below are key reports to facilitate an investment decision about Catalent Stock:
Check out Catalent Correlation with its peers.
For more information on how to buy Catalent Stock please use our How to Invest in Catalent guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Catalent Stock analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Catalent's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalent. If investors know Catalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.15)
Earnings Share
(7.18)
Revenue Per Share
22.623
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.01)
The market value of Catalent is measured differently than its book value, which is the value of Catalent that is recorded on the company's balance sheet. Investors also form their own opinion of Catalent's value that differs from its market value or its book value, called intrinsic value, which is Catalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalent's market value can be influenced by many factors that don't directly affect Catalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.